Arrhythmia following drug therapy
Schollmeyer, P.
Die Medizinische Welt 24(26): 1092-1096
1973
ISSN/ISBN: 0025-8512 PMID: 4730366 Document Number: 60357
Document emailed within 1 workday
Related Documents
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90Toivonen, L.; Heikkilä, J. 1986: Drug therapy of arrhythmia--ECG, a "cosmetic" or benefit to the patient? Duodecim; Laaketieteellinen Aikakauskirja 102(22): 1651-1661
Sulimov, V.A. 1999: "Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture] Terapevticheskii Arkhiv 71(8): 67-74
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Iskandar, S.B.; Byrd, R.P. 2006: Drug modified arrhythmia: what's your diagnosis? Tennessee Medicine: Journal of the Tennessee Medical Association 99(9): 37-38
Tao, S.Q. 1992: Drug treatment of ventricular arrhythmia Chinese Medical Journal 105(10): 795
Gronda, E.; Mangiavacchi, M.; Andreuzzi, B.; Municinò, A. 2001: Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(12): 1278-1283
Alboni, P. 1979: Is an electrophysiological study useful for the choice of anti-arrhythmia drug in patients with supraventricular paroxysmal tachycardia? Giornale Italiano di Cardiologia 9(5): 458-461
Lamarche, M.; Royer, R. 1971: Effect of a spironolactone, potassium canrenoate, on arrhythmia of the isolated auricle induced by a digitalic drug Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(6): 1432-1433
So, C.S. 1979: Arrhythmia. Diagnosis and therapy Medizinische Klinik 74(32-33): Preceding 1189
Lapińska, K.; Poplawska, W. 1970: Xylocaine in the therapy of arrhythmia Kardiologia Polska 13(1): 103-106
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Darpö, Börje. 2006: Drug-induced arrhythmia a difficult to catch adverse effect. New guidelines for increased cardiovascular safety Lakartidningen 103(14): 1094-1095
Shinya, H.; Hakoda, S.; Kinouchi, S. 2006: Plasma drug levels in amitriptyline overdose patient with complicated delayed cardiac arrhythmia and convulsions Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 19(3): 285-286
Knipping, W. 1980: Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents Medizinische Klinik 75(3): 108-115
So, C.S. 1979: Arrhythmia. Diagnosis and therapy. Pacemaker ECG Ii Medizinische Klinik 74(31): Preceding 1159
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389